isradipine has been researched along with Amyloid Deposits in 1 studies
Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wickline, JL | 1 |
| Smith, S | 1 |
| Shin, R | 1 |
| Odfalk, K | 1 |
| Sanchez, J | 1 |
| Javors, M | 1 |
| Ginsburg, B | 1 |
| Hopp, SC | 1 |
1 other study available for isradipine and Amyloid Deposits
| Article | Year |
|---|---|
L-type calcium channel antagonist isradipine age-dependently decreases plaque associated dystrophic neurites in 5XFAD mouse model.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Calcium Channel B | 2023 |